These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9248967)

  • 1. In vitro antibiotics testing and its relationship to clinical activity.
    Mouton Y; Dubreuil L
    J Chemother; 1997 May; 9 Suppl 1():93-9. PubMed ID: 9248967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad- versus narrow-spectrum antibiotic use: the role of in vitro testing and its correlation with clinical efficacy.
    Mouton Y; Senneville E
    Postgrad Med J; 1992; 68 Suppl 3():S68-72. PubMed ID: 1287621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of in-vitro susceptibility testing in the management of compromised hosts.
    Venditti M; Martino P
    J Chemother; 1997 May; 9 Suppl 1():116-22. PubMed ID: 9248970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro testing of antibiotics.
    Ackerman BH; Dello Buono FA
    Pharmacotherapy; 1996; 16(2):201-17. PubMed ID: 8820464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute otitis media disease management.
    Pichichero ME; Casey JR
    Minerva Pediatr; 2003 Oct; 55(5):415-38. PubMed ID: 14608265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions among antibiotics, bacteria and the human immune system: the clinical relevance of in vitro testing.
    Bergogne-Berezin E
    J Chemother; 1997 May; 9 Suppl 1():109-15. PubMed ID: 9248969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimicrobial activity of non-antibiotics: interactions with antibiotics.
    Neuman M
    APMIS Suppl; 1992; 30():15-23. PubMed ID: 1295541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial spectrum of an antibiotic and clinical categorization].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008 Jul; 56(5):300-4. PubMed ID: 18178037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for antimicrobial resistance in Chlamydia pneumoniae.
    Stamm WE
    J Infect Dis; 2000 Jun; 181 Suppl 3():S456-9. PubMed ID: 10839739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The contribution of the laboratory to the correct usage of antibiotics].
    Gialdroni Grassi G
    G Ital Chemioter; 1987; 34(1-3):11-8. PubMed ID: 3332868
    [No Abstract]   [Full Text] [Related]  

  • 16. Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox.
    Scortti M; Lacharme-Lora L; Wagner M; Chico-Calero I; Losito P; Vázquez-Boland JA
    Nat Med; 2006 May; 12(5):515-7. PubMed ID: 16633349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of glycopeptide antibiotics.
    Finch RG; Eliopoulos GM
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii5-13. PubMed ID: 15750036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Available laboratory tests to guide antimicrobial therapy.
    Araj GF
    J Med Liban; 2000; 48(4):199-202. PubMed ID: 11214189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prohost effect of antimicrobial agents as a predictor of clinical outcome.
    Labro MT
    J Chemother; 1997 May; 9 Suppl 1():100-8. PubMed ID: 9248968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
    Doern GV
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):821-35. PubMed ID: 17140358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.